GESTIÓN EN SALUD PÚBLICA

PBMs warn Trump’s proposal to disclose drug prices is illegal PBMs want transparency rule on ice, but drug companies also want prices to stay hidden

2026-04-20T07:57:00.000-07:00

https://www.statnews.com/2026/04/20/pbm-reform-proposal-draws-lobbyist-opposition/ By Bob HermanApril 20, 2026 Bob Herman is the author of Health Care Inc., an award-winning weekly newsletter about the business of health and medicine.

A controversy over research monkeys highlights ambiguity over health standards PETA accuses Pfizer of jeopardizing animal welfare and scientific integrity

2026-04-20T07:56:00.000-07:00

https://www.statnews.com/pharmalot/2026/04/20/animal-testing-peta-questions-pfizer-research-monkey-health/ By Ed SilvermanApril 20, 2026 Pharmalot Columnist, Senior Writer

Even for trans adults, care is hard to find: ‘I could not do it on my own’ By Theresa GaffneyApril 20, 2026

2026-04-20T07:54:00.000-07:00

Even for trans adults, care is hard to find: ‘I could not do it on my own’ How an LGBTQ+ center in Georgia is expanding trans medical care while it shrinks elsewhere https://www.statnews.com/2026/04/20/transgender-adults-caught-in-youth-gender-affirming-care-policies/

Viewpoint — AI doomsday projections: Will social media save us or make the panic worse? Nitasha Tiku | Washington Post | April 20, 2026

2026-04-20T07:53:00.000-07:00

https://geneticliteracyproject.org/2026/04/20/viewpoint-ai-doomsday-projections-will-social-media-save-us-or-make-the-panic-worse/

Does free will exist? Why you may have no choice but to read this article Sarah Scoles | MIT Review | April 20, 2026

2026-04-20T07:52:00.000-07:00

https://geneticliteracyproject.org/2026/04/20/does-free-will-exist-why-you-may-have-no-choice-but-to-read-this-article/

Despite disease surges, poll shows Kennedy-driven disinformation has left most Americans skeptical of vaccines Lauren Gardner | Politico | April 20, 2026

2026-04-20T07:51:00.000-07:00

https://geneticliteracyproject.org/2026/04/20/despite-disease-surges-poll-shows-kennedy-driven-disinformation-has-left-most-americans-skeptical-of-vaccines/

Viewpoint: ‘Make America Healthy Again” appeals to fake nostalgia about non-existent golden age Joe Schwarcz | April 20, 2026

2026-04-20T07:49:00.001-07:00

https://geneticliteracyproject.org/2026/04/20/viewpoint-make-america-healthy-again-appeals-to-fake-nostalgia-about-non-existent-golden-age/

Regulatory Education for Industry (REdI) Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products May 19 - 20, 2026

2026-04-20T07:49:00.000-07:00

https://www.fda.gov/news-events/regulatory-education-industry-redi-annual-conference-2026-innovative-regulatory-strategies-advance?utm_medium=email&utm_source=govdelivery

Eight Trends Shaping 2026 Healthcare Costs March 17, 2026

2026-04-20T07:47:00.000-07:00

https://www.healthsystemtracker.org/

Viewpoints: 340B Is Driving Up Hospital Prices; Measles Dramatically Alters Lives Of Immunocompromised

2026-04-20T07:46:00.000-07:00

https://kffhealthnews.org/morning-breakout/viewpoints-340b-is-driving-up-hospital-prices-measles-dramatically-alters-lives-of-immunocompromised/

Dangerous Fentanyl Substitute Carfentanil Sees Alarming Surge

2026-04-20T07:45:00.000-07:00

Dangerous Fentanyl Substitute Carfentanil Sees Alarming Surge Officials warn carfentanil, which is a weapons-grade chemical that is 100 times stronger than fentanyl, is spreading across the United States and causing fatal overdoses. A poppy seed-sized amount can be lethal. https://kffhealthnews.org/morning-breakout/dangerous-fentanyl-substitute-carfentanil-sees-alarming-surge/

La. Father Who Killed 8 Kids Struggled With Mental Health, Family Says

2026-04-20T07:44:00.000-07:00

La. Father Who Killed 8 Kids Struggled With Mental Health, Family Says Authorities say Shamar Elkins, 31, fatally shot eight children — seven of them his own — who ranged in age from 1 to 14, The New York Times reported. He also shot two others, including his wife, before leading police in a car chase that ended in gunfire. It's unclear whether Elkins took his own life or was shot by police. He had recently expressed suicidal thoughts, family members said. https://kffhealthnews.org/morning-breakout/la-father-who-killed-8-kids-struggled-with-mental-health-family-says/

Using Organ Donor Immune Cells Can Help Avoid Organ Rejection: Study

2026-04-20T07:43:00.000-07:00

Using Organ Donor Immune Cells Can Help Avoid Organ Rejection: Study Although the study was effective in only three of the eight participants, experts hope this partial success will lead to breakthroughs that allow transplant patients to no longer need anti-rejection drugs, which suppress the body’s immune response and can lead to serious health consequences. https://kffhealthnews.org/morning-breakout/using-organ-donor-immune-cells-can-help-avoid-organ-rejection-study/

Employers Shopping Around For Health Care Coverage Amid Rising Costs

2026-04-20T07:42:00.000-07:00

Employers Shopping Around For Health Care Coverage Amid Rising Costs The percentage of members of the Purchaser Business Group on Health who are shopping between insurance providers has risen 25 points since 2024, Healthcare Dive reported. https://kffhealthnews.org/morning-breakout/employers-shopping-around-for-health-care-coverage-amid-rising-costs/

Trump Gives Go-Ahead To Fast-Track Psychedelics For Mental Health Illness

2026-04-20T07:41:00.000-07:00

Trump Gives Go-Ahead To Fast-Track Psychedelics For Mental Health Illness President Trump's executive order directs federal agencies to ease restrictions that have prevented scientists from studying the use psychedelic drugs to treat myriad mental health challenges. It also opens up some of the investigational drugs for use in patients, The New York Times reported. https://kffhealthnews.org/morning-breakout/trump-gives-go-ahead-to-fast-track-psychedelics-for-mental-health-illness/

RFK Jr. Defends Health Care Agenda: ‘I’m Not Anti-Vax. I’m Pro Science.’

2026-04-20T07:32:00.000-07:00

RFK Jr. Defends Health Care Agenda: ‘I’m Not Anti-Vax. I’m Pro Science.’ On Friday, lawmakers on Capitol Hill grilled HHS Secretary Robert F. Kennedy Jr. about his stance on the measles vaccine, his thoughts about whether Donald Trump is fit to be president, and his take on autism and gender-affirming care. Plus, CDC workers are "guarded but hopeful" that Erica Schwartz could be the agency's next leader. https://kffhealthnews.org/morning-breakout/rfk-jr-defends-health-care-agenda-im-not-anti-vax-im-pro-science/

The Accidental Architect of America’s Drug Patent Problem Season 15, Episode 5 April 20, 2026

2026-04-20T07:31:00.000-07:00

https://kffhealthnews.org/news/podcast/an-arm-and-a-leg-alfred-engelberg-accidental-architect-drug-patent-thicket/ KFF Health News: KFF Health News’ ‘An Arm and a Leg’: The Accidental Architect Of America’s Drug Patent Problem Depending on whom you ask, Alfred Engelberg could be a hero or a villain in the story of American pharmaceuticals. The patent lawyer helped write legislation that led to a dramatic increase in the number of generic drugs on the market. He also contributed to a patent system that gives pharmaceutical companies monopolies on their most lucrative drugs, blocking generic competition and keeping prices high along the way. (Weissmann, 4/20)

In Connecticut, Doctors Now Sue Patients Most Over Medical Bills, Surpassing Hospitals By Noam N. Levey and Katy Golvala and Jenna Carlesso, CT Mirror April 20, 2026

2026-04-20T07:29:00.000-07:00

https://kffhealthnews.org/news/article/medical-debt-connecticut-doctors-sue-patients/ KFF Health News: In Connecticut, Doctors Now Sue Patients Most Over Medical Bills, Surpassing Hospitals Many hospital systems in Connecticut have stopped suing their patients over unpaid bills, stung by criticism about the harm caused by aggressive collection tactics. But physicians, dentists, ambulance companies, and other health care providers are still taking their patients to court, a Connecticut Mirror-KFF Health News investigation of state legal records shows. Lawsuits by doctors and other nonhospital providers now dominate health care collections in Connecticut, the records show, accounting for more than 80% of cases filed against patients and their families in 2024. (Levey, Golvala and Carlesso, 4/20)

How employers support lower-waged workers’ access to health insurance options By Gary Claxton, Lynne Cotter, Cynthia Cox Twitter, Matthew McGough, Nirmita Panchal, Emma Wager Twitter, and Matthew Rae Twitter KFF April 20, 2026

2026-04-20T07:26:00.000-07:00

https://www.healthsystemtracker.org/chart-collection/how-employers-support-lower-waged-workers-access-to-health-insurance-options/?utm_campaign=KFF-Health-Costs&utm_medium=email&_hsenc=p2ANqtz-_RAVuJCaFDjcLB9D93-miYZH-xWxD_0wT9E0lIMhOluK9BUcJsmgSlIsp8EGHQVJ6imW1BldsICi9cyzFYuM0mybmkWQ&_hsmi=414669537&utm_content=414669537&utm_source=hs_email Lower-Paid Workers Are More Likely to Go Without Health Insurance Due to Access and Costs Health insurance makes up 8% of total employee compensation on average, and while most employees take up health insurance when it is offered, lower-wage workers are far less likely to be able to access coverage, according to a new KFF analysis of survey data and focus groups with more than 100 U.S. employers with over a quarter of a million employees. About three in four employees are offered health insurance on average, and nearly two-thirds of those offered insurance enroll in the benefit. Workers in occupations with lower wages, such as service occupations, are much less likely to have access to health benefits at their jobs (94% of workers in higher-wage jobs vs. 44% in lower-wage jobs) and, even when they do, they are much less likely to enroll (72% vs. 49%). Employers say the high price of premiums is a barrier to enrollment, particularly for hourly, lower-wage workers, and only a small proportion offer premium or cost-sharing support for workers with lower wages. Large employers are the most likely to offer additional support with premiums and cost-sharing for lower-wage workers. Contact: Tammie Smith | 202-654-1410 | tammies@kff.org

ACI’s 2nd Annual Summit on GLP-1 Law & Policy April 20, 2026

2026-04-20T07:02:00.000-07:00

https://www.thefdalawblog.com/2026/04/acis-2nd-annual-summit-on-glp-1-law-policy/?utm_source=rss&utm_medium=rss&utm_campaign=acis-2nd-annual-summit-on-glp-1-law-policy The GLP-1 market is set to hit over $30 billion by 2030. Intellectual property litigation and FDA crackdowns have led to a boom in M&A and partnership activity. Long-term patient effects have yet to be fully realized. The future of GLP-1s is bright, but ownership, liability, and regulatory priorities still hang in the balance. That’s the backdrop for the American Conference Institute’s (“ACI”) 2nd Annual Summit on GLP-1 Law & Policy, which returns on June 4, 2026, at 3 Times Square, New York, NY.

The podcast bringing together MAHA and public health for hard conversations ‘Why Should I Trust You?’ takes a new approach to controversial health topics

2026-04-19T07:14:00.000-07:00

https://www.statnews.com/2026/04/18/maha-public-health-why-should-i-trust-you-podcast/ By Torie BoschApril 18, 2026 Editor, First Opinion

How Trump is pushing psychedelics reform through the health agencies Saturday’s executive order comes, in part, because of a text message from influential podcaster Joe Rogan

2026-04-19T07:13:00.000-07:00

https://www.statnews.com/2026/04/18/psychedelics-ptsd-mental-health-research-boost-from-trump-executive-order/ By Daniel PayneApril 18, 2026 Washington Correspondent

A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment An investigator in a trial of daraxonrasib believes it could open the floodgates for better therapies

2026-04-19T07:11:00.000-07:00

https://www.statnews.com/2026/04/17/revolution-medicines-daraxonrasib-clinical-trial-readout-loud-podcast-transcript/ By Adam Feuerstein, Allison DeAngelis, and Elaine ChenApril 17, 2026

The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades Long pursuit of common mutation appears to be paying off for patients and for Revolution Medicines

2026-04-19T07:09:00.000-07:00

https://www.statnews.com/2026/04/19/daraxonrasib-pancreatic-cancer-kras-revolution-medicines-patient-story/ By Angus ChenApril 19, 2026 Angus Chen angus.chen@statnews.com

Abortion: the possibilities of progress The Lancet ++...

2026-04-19T07:07:00.000-07:00

Abortion: the possibilities of progress The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00753-1/fulltext?dgcid=raven_jbs_etoc_email Apr 18, 2026 Volume 407Number 10538p1483-1572 https://www.thelancet.com/journals/lancet/issue/vol407no10538/PIIS0140-6736(26)X2013-X